A positive feedback loop between YTHDC1 and EP300 drives multiple myeloma tumorigenesis.
Functional studies reveal that YTHDC1 facilitates MM cell growth and survival in an m6A-dependent manner and highlight the YTHDC1-EP300 axis as a promising target for therapeutic intervention.